[Molecular mechanisms of dormancy and drug tolerance in mycobacteria]

Nihon Hansenbyo Gakkai Zasshi. 2013 Dec;82(3):119-22. doi: 10.5025/hansen.82.119.
[Article in Japanese]

Abstract

Instead of rapid multiplication, pathogenic mycobacteria, such as Mycobacterium tuberculosis are likely to have acquired slow but long life. Host immunity affords desirable non-competitive environment for M tuberculosis in human lungs, where this pathogen slowly grows or arrests growing, which avoids rapid loss of living places. Mycobacterial DNA-binding protein 1 (MDP1), a unique histone-like protein associating mycobacterial GC-rich DNA, has pivotal role in realizing such slow life and pathogenesis including drug tolerance to isoniazid.

Publication types

  • Review

MeSH terms

  • Animals
  • Antitubercular Agents / pharmacology*
  • Bacterial Physiological Phenomena / genetics*
  • Bacterial Proteins / physiology
  • DNA-Binding Proteins / physiology
  • Drug Resistance, Bacterial / genetics*
  • Humans
  • Isoniazid / pharmacology*
  • Lung / microbiology
  • Mycobacterium tuberculosis / drug effects*
  • Mycobacterium tuberculosis / genetics
  • Mycobacterium tuberculosis / growth & development*
  • Mycobacterium tuberculosis / pathogenicity

Substances

  • Antitubercular Agents
  • Bacterial Proteins
  • DNA-Binding Proteins
  • MDP1 protein, Mycobacterium
  • Isoniazid